XML 28 R17.htm IDEA: XBRL DOCUMENT

Legal Settlements and Loss Contingencies	3 Months Ended
Mar. 31, 2022
Legal Settlements and Loss Contingencies	NOTE 9 – Legal settlements and loss contingencies: In the first quarter of 2022, Teva recorded expenses of $1,124 million in legal settlements and loss contingencies, compared to $104 million in the first quarter of 2021. The expenses in the first quarter of 2022 were mainly related to an update of the estimated settlement provision recorded in connection with the remaining opioid cases. The expenses in the first quarter of 2021 were mainly due to the provision for the carvedilol patent litigation. As of March 31, 2022 and December 31, 2021, Teva’s provision for legal settlements and loss contingencies recorded under accrued expenses and other taxes and long-term liabilities was $3,762 million and $2,710 million, respectively. In connection with Teva’s provision for legal settlements and loss contingencies as of March 31, 2022 and December 31, 2021, related to the Ontario Teachers Securities Litigation, Teva also recognized an insurance receivable.

Legal Settlements and Loss Contingencies

3 Months Ended

Mar. 31, 2022

Legal Settlements and Loss Contingencies

NOTE 9 – Legal settlements and loss contingencies:

In the first quarter of 2022, Teva recorded expenses of $1,124 million in legal settlements and loss contingencies, compared to $104 million in the first quarter of 2021. The expenses in the first quarter of 2022 were mainly related to an update of the estimated settlement provision recorded in connection with the remaining opioid cases. The expenses in the first quarter of 2021 were mainly due to the provision for the carvedilol patent litigation.

As of March 31, 2022 and December 31, 2021, Teva’s provision for legal settlements and loss contingencies recorded under accrued expenses and other taxes and long-term liabilities was $3,762 million and $2,710 million, respectively. In connection with Teva’s provision for legal settlements and loss contingencies as of March 31, 2022 and December 31, 2021, related to the Ontario Teachers Securities Litigation, Teva also recognized an insurance receivable.